VACCINE PNEUMOCOCCAL polysacch.. 23, monodose, 0.5ml syr.
STD
DVACVPPV23S
Valid Article
Account code:
60010
HS Code:
300241
Last Updated on:
12/04/2024, 18:27:25
Former
Code(s):
DVACZBD0032 DVACVPNE23S
19.3 - Vaccines
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J07AL01
Anatomical Therapeutic Chemical Classification according to WHOCC
OC subscriptions: included in supply or field order tools (e.g. UniField)
|
|
SC subscriptions: included in supply or field tools
|
|
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
|
|
VACCINE PNEUMOCOCCAL POLYSACCHARIDE 23
Therapeutic Action
Polysaccharide pneumococcal vaccine containing 23 pneumococcal serotypes
Indications
Active immunisation against pneumococcal disease in children from 2 years of age, adolescents and adults
MSF recommends its use in people with functional or surgical asplenia and HIV seropositive children and adults.
Some restricted information has been hidden. Sign in
to see this information
Instructions for use
Suspension in a liquid form
0.5 ml single-dose to be given by IM or SC route.
To be administered to people with asplenia and people HIV seropositive, in addition to the PCV vaccine. Consult your medical department.
Precautions for Use
As with all injectable vaccines and/or immunoglobulins, appropriate medical treatment should always be readily available in case of rare anaphylactic reactions following the administration of the product.
Storage
- Keep refrigerated between 2ºC and 8ºC
- Do not freeze.